Literature DB >> 3585032

New 23-valent pneumococcal vaccine in relation to pneumococcal serotypes in systemic and non-systemic disease.

L E Smart, A J Dougall, R W Girdwood.   

Abstract

The serotype distribution of 3631 strains of Streptococcus pneumoniae, isolated from various specimens obtained from patients was determined by coagglutination and included serotyping within a total of 13 serogroups. The results of serotyping of isolates from Scotland demonstrated that the new 23-valent pneumococcal vaccine includes serotypes which accounted for 91% strains associated with systemic disease and 79% strains isolated from other anatomical sites. Altogether, 114 strains (3.1%) were not typable because they did not possess a type-specific capsule; these were commonly isolated from eyes (12%).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3585032     DOI: 10.1016/s0163-4453(87)93360-3

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  6 in total

1.  Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization.

Authors:  Leen Moens; Philippe Hermand; Tine Wellens; Greet Wuyts; Rita Derua; Etienne Waelkens; Carine Ysebaert; Fabrice Godfroid; Xavier Bossuyt
Journal:  Hum Vaccin Immunother       Date:  2018-02-21       Impact factor: 3.452

2.  A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae.

Authors:  Philippe Denoël; Mario T Philipp; Lara Doyle; Dale Martin; Georges Carletti; Jan T Poolman
Journal:  Vaccine       Date:  2011-05-30       Impact factor: 3.641

Review 3.  The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.

Authors:  Amber M Smith; Victor C Huber
Journal:  Viral Immunol       Date:  2017-11-17       Impact factor: 2.257

4.  Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens.

Authors:  Fabrice Godfroid; Philippe Hermand; Vincent Verlant; Philippe Denoël; Jan T Poolman
Journal:  Infect Immun       Date:  2010-10-18       Impact factor: 3.441

5.  Serotypes and resistance patterns of Streptococcus pneumoniae causing systemic disease in northern Norway.

Authors:  T Magnus; B M Andersen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

6.  Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen.

Authors:  Philippe Hermand; Annick Vandercammen; Emmanuel Mertens; Emmanuel Di Paolo; Vincent Verlant; Philippe Denoël; Fabrice Godfroid
Journal:  Hum Vaccin Immunother       Date:  2016-10-21       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.